Pink Sheet Editor-in-Chief Nielsen Hobbs, executive editor Derrick Gingery, and senior reporter Maaisha Osman discuss new FDA commissioner nominee Heidi Overton, her prospects for confirmation, and what her pick means for the agency. More On The Topic From The Pink Sheet FDA Commissioner Nominee Has The White House’s Trust. Winning Over Career Staff Is Another Matter: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/fda-commissioner-nominee-has-the-white-houses-trust-winning-over-career-staff-is-another-matter-IIZWK46CFVHMBIZF5XM7L4PQ6U/ Trump To Nominate White House Advisor Overton As FDA Commissioner: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/outgoing-georgia-congressman-buddy-carter-eyed-for-fda-commissioner-RHIYQUYTIVGRTFEXYCHCWPG54Y/

Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency

Citeline Podcasts

Hello and welcome to another edition of Drug Fix, Pink Sheets' far more regulatory podcast. I'm Nielsen Hobbs, Editor-in-Chief of the aforementioned Sheet of Pink, and today is August 21st, 2026. I imagine everyone listening can already guess what the topic is this week. That's right, the new Container Closure Guidance is out. No, no, I'm kidding. It's the new FDA Commissioner Nominee Heidi Overton. Joining me to talk about her selection is Executive Editor Derek Gingery and Senior Reporter

Maisha Osmond. Maisha, you've been writing the stories about Overton for Pink this week. Who is she? How did you get the nod and what happens next? Yeah, so credentials first. She's got an MD from University of New Mexico and a PhD in clinical investigations from Johns Hopkins. So she isn't someone who just wandered off the street. She has academic chops, but here's the thing.

Her career hasn't really been in medicine or running organizations. So it's been almost entirely in policy and politics. So she was a White House fellow under Trump's first term. Then she went to this think tank called the America First Policy Institute, where she was basically helping develop and promote Trump-aligned health policies.

So she's been in Trump's orbit for a while. And she's described as someone who's really good at managing up rather than managing down. So meaning she's got the White House trust and she knows how to get things done politically.

Right. So, yeah, I know we had reported her as being on a short list over the summer and now they'll listen to a shortened to one. And she's, you know, she'll face a Senate confirmation hearing.

Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.